Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Geologica Closes Financing And Property Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVMZ


Primary Symbol: PAVM

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

PAVmed Appoints Shaun O'Neil as Chief Operating Officer

Business Wire February 24, 2022

Evernorth Executive and Healthcare Services Industry Leader Joan Harvey Named to PAVmed Board of Directors

Business Wire February 15, 2022

Lucid Diagnostics to Participate in a Fireside Chat at the BTIG MedTech Digital Health, Life Science, and Diagnostics Tools Conference

Business Wire February 10, 2022

PAVmed and Lucid Diagnostics Welcome New Full-Time Investor Relations Team

Business Wire January 12, 2022

Lucid Diagnostics to Participate in a Fireside Chat at the 24th Annual Needham Virtual Growth Conference

Business Wire January 6, 2022

PAVmed Subsidiary Lucid Diagnostics Launches EsoGuard Telemedicine Program in Partnership with UpScriptHealth

Business Wire December 1, 2021

Lucid Diagnostics to Present at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Business Wire November 17, 2021

PAVmed and Lucid Provide Business Update and Preliminary Third Quarter 2021 Financial Results

Business Wire November 16, 2021

PAVmed Subsidiary Lucid Diagnostics Launches Next Phase of Lucid Test Centers

Business Wire November 11, 2021

PAVmed and Lucid to Hold Joint Business Update Conference Call on November 16, 2021

Business Wire November 3, 2021

Veris Health Showcased in PAVmed Digital Health Virtual Investor Event

Business Wire October 29, 2021

Lucid Diagnostics' EsoGuard Esophageal DNA Test Wins "Diagnostics Innovation of the Year" Award

Business Wire October 28, 2021

PAVmed Digital Health Subsidiary Veris Health Appoints Sunny Webb as Chief Technology Officer

Business Wire October 25, 2021

Lucid Diagnostics Appoints Suman Verma MD, PhD as Chief Scientific Officer

Business Wire October 21, 2021

Lucid Diagnostics Announces Closing of Nasdaq Initial Public Offering

GlobeNewswire October 18, 2021

Lucid Diagnostics Announces Pricing of Initial Public Offering

Business Wire October 13, 2021

PAVmed Acquires EsophaCap Manufacturer CapNostics LLC

Business Wire October 7, 2021

PAVmed to Host Digital Health Virtual Investor Event

Business Wire September 30, 2021

PAVmed Subsidiary, Lucid Diagnostics, Files Registration Statement for Proposed Initial Public Offering

Business Wire September 23, 2021

PAVmed Subsidiary Veris Health Joins Microsoft for Startups Global Program and Engages Loka as Software Development Partner

Business Wire September 21, 2021